Aspiro Therapeutics Named Finalist in Flinn Foundation Bioscience Entrepreneurship Program
Tucson, AZ / March 7, 2025 – Aspiro Therapeutics, a biotechnology company developing next-generation treatments for obstructive lung diseases, has been selected as a finalist in the Flinn Foundation Bioscience Entrepreneurship Program. The program recognizes Arizona-based bioscience startups with high-impact innovations poised to improve human health. Aspiro is focused on advancing disease-modifying therapies for respiratory […]